Microwave ablation combined with atrial size reduction during open-heart surgery significantly increased freedom from atrial fibrillation at 12 months compared to control (80% vs. 33.3%, P=0.036).
RCT (n=43)
randomly stratified
Absolute Event Rate: 80% vs 33.3%
p-value: p=0.036
OBJECTIVE: Radiofrequency or the use of microwave energy in combination with atrial size reduction during open heart surgery have been reported to be effective in up to 75% in the treatment of permanent atrial fibrillation. However, no data from prospective randomized trials using microwave energy are available. METHODS: Forty-three patients with permanent atrial fibrillation undergoing open-heart surgery were randomly stratified into treatment group receiving microwave ablation and atrial size reduction (n=24) or control group (n=19). Patients in either group were treated with amiodarone or sotalol for 3 months if sinus rhythm or any atrioventricular rhythm was successfully restored. Follow-up time points were at 3, 6 and 12 month after surgery. RESULTS: In the treatment group 22 out of 24 patients (91,7%) were successfully converted to sinus rhythm by using intraoperative microwave ablation therapy whereas only six out of 19 (31.5%) patients converted to sinus rhythm directly after surgery. At 12-month follow-up there were still a significantly higher percentage of patients in the treatment group free from atrial fibrillation when compared to control (80 vs. 33.3%, P=0.036). CONCLUSION: The preliminary data from this first prospectively randomized trial indicate that microwave ablation combined with atrial size reduction is a safe and highly efficient treatment in permanent atrial fibrillation.
Schüetz et al. (Tue,) conducted a rct in permanent atrial fibrillation (n=43). microwave ablation and atrial size reduction vs. control group (open-heart surgery alone) was evaluated on freedom from atrial fibrillation at 12-month follow-up (p=0.036). Microwave ablation combined with atrial size reduction during open-heart surgery significantly increased freedom from atrial fibrillation at 12 months compared to control (80% vs. 33.3%, P=0.036).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: